Algocyte helps doctors monitor patients' health whenever necessary, wherever they are.

Algocyte helps medical professionals remotely monitor their patients with conditions such as leukaemia and other types of cancer, as well as conditions like anaemia, infection or inflammation, autoimmune and other blood cell disorders. Using AI, Algocyte provides an end-to-end medically-driven solution for remote blood testing and health monitoring, from tracking to risk assessment, analytics, and decision support.

What we do
Clear testing to transform healthcare 

Instead of performing a large battery of medically unnecessary tests, Algocyte is medically driven and performs a wide range of hematological and biochemical tests. With all the data collected, Algocyte generates a more precise profile of an individual's health than is possible using single 'snapshots', as is often done.

Algocyte is created by Oxford Immune Algorithmics

Algocyte is originally from Reading, UK, developed by a team from Oxford Immune Algorithmics, which represents the breadth of the company’s core areas: AI & Computer Vision, Biomedicine, App and Cloud development, IoT Engineering and Market Innovation.

The team behind Algocycte consists of AI experts, medical leaders, pioneers in IoT and optical engineering at the forefront of science and technology. They are able to tackle some of the most pressing human health challenges such as cancer, infection, antibiotic resistance and tropical diseases.

Follow us on Linkedin, Twitter, Facebook 
Download on the App Store or Google Play

Who we are
Chief Financial Officer - Algocyte

Lionel Khalil

“Our team is thrilled to join Hub71 in Abu Dhabi. Being part of the Hub71 family is a great achievement for us. The great support of their Incentive Program is a boost for our company, to access the regional ecosystem.”

Lionel Khalil

Join our Community

There are countless reasons to join our growing Hub71 community - keep an eye out for our next cohort